MARS人工肝治疗肝移植术后患者一例报告.PDFVIP

190 Chin J Clini Hepatol ,June 2004 ,Vol 20 ,No3 [J ] . Scand J Ganstronterol , 1997 , 32 ∶1052 - 1055 . [ 13 ] Kim SJ , Takai SI , Kimoto Y , et al . The expression of urokinase type [8 ] Seki T , Imai H , Uno S , et al . Production of tissue - type plasminogen plasminogen activator is a novel prognostic factor in dukes B and C col ( ) ( ) ( ) activator t - PA and type 1 plasminogen activator inhibitor PAI - 1 in orectal cancer [J ] . Oncol Rep , 1998 ,5 2 ∶431 - 433 . mildly cirrhotic rat liver [J ] . Throb Haemost , 1996 ,75 ∶801 - 803 . [ 14 ]王业东 ,赵景民,辛少杰 ,等. 尿激酶型纤溶酶原激活剂及其抑制 [9 ]秦成勇 ,劳萍 ,李清华. 溶酶原激纤活物抑制物在纤维化肝组织中 剂 PAI - 1mRNAs 的表达与人肝细胞癌的关系[J ] . 解放军医学杂 ( ) ( ) 的表达及其血浆活性检测[J ] . 中华肝脏病杂志 ,2000 ,8 4 ∶209 - 志 ,1999 ,24 2 ∶104 - 106 . 211. [ 15 ] Grondahl - Hansensen J , Christe U , Rosenquist C , et al . High levels of [ 10 ] 范建高 ,陈良华 , 曾民德 ,等. 高脂血症脂肪肝家兔肝脏纤溶酶原 urokinase type plasminogen activator and its inhibitor PAI - 1 in cytosolic 激活物抑制物 1 型基因表达[J ] . 中华消化杂志 ,2000 ,20 (4) ∶246 exstacts of breast carcinomas are associated with poor prognosis [J ] . Can - 248. cer Res , 1993 ,53 ∶2513 - 2515 . [ 11]郑起 ,汤钊猷 ,吴志全 ,等. 溶酶原激纤活物抑制物 1 与肝细胞癌 [ 16 ]吴志全 ,郑起 ,汤钊猷. 肝癌患者血浆和肿瘤组织中 PAI - 1 变化 [J ] . 中华外科杂志 ,1998 ,36 (8) ∶474 - 476 . [J ] . 中华消化杂志 ,1999 ,19 ( 1) ∶16 - 18. [ 12 ]Umeda T , Hattori T , Kodama M , et al . Cellar localization of urokinase [ 17 ]朱运松 ,郑起 ,汤钊猷 ,等. 尿激酶型纤溶酶原激活物及其特异受 - type plasm